Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Arena Sees Phase III Path For Etrasimod After Atopic Dermatitis Miss
Analysts Agreed The S1P Receptor Modulator Should Advance
Nov 11 2020
•
By
Mandy Jackson
Arena identified a path forward for etrasimod in atopic dermatitis • Source: Shutterstock
More from Clinical Trials
More from R&D